We may thus speculate that regular medications in COPD patients result in decreased sCD86 serum levels either due to reduced shedding of the CD86 from the cell membrane or due to the reduced expression of surface-bound CD86 on antigen-presenting cells. Here, CD86 is linked to chronic obstructive pulmonary disease.